Becciolini, A.; Parisi, S.; Caccavale, R.; Bravi, E.; Lumetti, F.; Andracco, R.; Volpe, A.; Gardelli, L.; Girelli, F.; Di Donato, E.;
et al. Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis. J. Pers. Med. 2022, 12, 335.
https://doi.org/10.3390/jpm12030335
AMA Style
Becciolini A, Parisi S, Caccavale R, Bravi E, Lumetti F, Andracco R, Volpe A, Gardelli L, Girelli F, Di Donato E,
et al. Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis. Journal of Personalized Medicine. 2022; 12(3):335.
https://doi.org/10.3390/jpm12030335
Chicago/Turabian Style
Becciolini, Andrea, Simone Parisi, Rosalba Caccavale, Elena Bravi, Federica Lumetti, Romina Andracco, Alessandro Volpe, Lucia Gardelli, Francesco Girelli, Eleonora Di Donato,
and et al. 2022. "Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis" Journal of Personalized Medicine 12, no. 3: 335.
https://doi.org/10.3390/jpm12030335
APA Style
Becciolini, A., Parisi, S., Caccavale, R., Bravi, E., Lumetti, F., Andracco, R., Volpe, A., Gardelli, L., Girelli, F., Di Donato, E., Santilli, D., Lucchini, G., Ditto, M. C., Platè, I., Arrigoni, E., Mozzani, F., Riva, M., Marchetta, A., Fusaro, E.,
... Ariani, A.
(2022). Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis. Journal of Personalized Medicine, 12(3), 335.
https://doi.org/10.3390/jpm12030335
